An HIV diagnosis does not have the same meaning today as when the virus first emerged in the 1980s. People […]
Since its introduction in 1992, the 340B Program has vastly altered the pharmacy landscape. In these very uncertain times, as […]
Finance guys like myself often have the reputation of being unwilling to spend money. However, we can always be convinced […]
A patient newly diagnosed with HIV can often feel as if the cards are stacked against them before they even […]
The challenges that ‘white bagging’ poses for patients and providers are gaining attention as more health plans mandate these policies. […]
Safety net facilities are celebrating the May 17 HRSA letters to six drug manufacturers affirming they must provide drugs to […]
Those of us actively engaged in the 340B Program are well aware of the scores of issues faced by participating […]
For years, covered entities generated savings from the 340B program largely by contracting with retail pharmacies. Brick-and-mortar storefronts in their […]
The devastating double-whammy of Medicare Part B payment cuts and COVID-19 has again highlighted the 340B program’s significance to hospital […]
It’s becoming increasingly difficult for Covered Entities (CEs) to effectively manage their 340B pharmacy programs. Often times understaffed relative […]